HR+ HER2- Breast Cancer
specificEarly detection of breast cancer involving asymptomatic women. Generally done in the population with higher risk, due to environmental or genetic factors.
16
Centers
8
Active Trials
—
Cancer Funding
Top Centers for HR+ HER2- Breast Cancer(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 64.4 |
| 2 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 64.4 |
| 3 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 64.4 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 64.4 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 64.4 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 64.4 |
| 7 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 64.4 |
| 8 | Boston University Cancer CenterBoston, MA Active Research Program | 64.4 |
| 9 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 41.9 |
| 10 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 41.9 |
| 11 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | 41.9 |
| 12 | NCI Comprehensive | 41.9 |
| 13 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 41.9 |
| 14 | University of Illinois Cancer CenterChicago, IL | 41.9 |
| 15 | Princess Margaret Cancer CentreToronto, ON | 41.9 |
| 16 | BC CancerVancouver, BC | 41.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →